SpyGlass Pharma, Inc. Basic Shares Outstanding (Weighted Average)
SpyGlass Pharma, Inc. (SGP) reported Basic Shares Outstanding (Weighted Average) of 33.44 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- SpyGlass Pharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 33.44M shares, a 1368.24% increase year-over-year.
- SpyGlass Pharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 19.93M shares, a 793.77% increase year-over-year.
- SpyGlass Pharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 2.28M shares.
- SpyGlass Pharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-03-31 was 2.23M shares.
- SpyGlass Pharma, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 2.22M shares, a 23.98% increase from fiscal 2024.
- SpyGlass Pharma, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 1.79M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|
| 2026-06-30 | 33.44M shares 10-Q · filed 2026-08-06 | 26.72M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 19.93M shares 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | 2.22M shares 10-K · filed 2026-03-26 | ||
| 2025-06-30 | 2.28M shares 10-Q · filed 2026-08-06 | 2.25M shares 10-Q · filed 2026-08-06 | |
| 2025-03-31 | 2.23M shares 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | 1.79M shares 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |